Vnitr Lek 2005, 51(4):438-449

Molecular pathophysiology of late diabetic complications - genetic predisposition to the development of diabetic complications

K. Kaňková
Ústav patologické fyziologie Lékařské fakulty MU, Brno, přednostka prof. MUDr. Anna Vašků, CSc.

Our contribution deals with a subject of genetic determination of susceptibility to the development of late diabetic complications, ways and means of its study and potential clinical application of this piece of knowledge for assessing of individual's risk. Existence of genetic risk factors for diabetic complications is supported by (i) data regarding the relationship between prevalence and incidence of complications on one hand and diabetes duration and compensation on the other, (ii) frequent proof of familiar aggregation and (iii) results of segregation analyses. Aforementioned facts apply almost exclusively to the diabetic nephropathy and macrovascular disease. Pathogenically, functional variability in relevant metabolic and hemodynamic parameters as a result of genetic variability seems to play a role. Genetic component of susceptibility to diabetic complications exhibits, from the point of view of genetics, features of so-called complex disease. We summarise meaningful and the most significant results of linkage and association studies of genetics of diabetic nephropathy and cardiovascular diseases accompanying diabetes in detail.

Keywords: diabetes mellitus; diabetic complications; diabetic nephropathy; association; polymorphism; complex disease

Received: May 10, 2004; Accepted: June 21, 2004; Published: April 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kaňková K. Molecular pathophysiology of late diabetic complications - genetic predisposition to the development of diabetic complications. Vnitr Lek. 2005;51(4):438-449.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kaňková K. Molecular pathophysiology of late diabetic complications - hyperglycemia-induced changes. Vnitř Lék 2004; 50: 756-767. Go to PubMed...
    2. Strowig S, Raskin P. Glycemic control and diabetic complications. Diabetes Care 1992; 15: 1126-1140. Go to original source... Go to PubMed...
    3. Barbosa J. Nature and nurture: The genetics of diabetic microangiopathy In: Podolsky S, Viswanathan M (eds). Secondary diabetes. The spectrum of diabetic syndromes. New York: Raven Press 1980.
    4. Kaňková K. Role of genetic variability in systems of receptor-mediated and enzymatic defence against glycation in the long-term consequences of diabetes mellitus. Biochem Soc Trans 2003; 31: 1364-1366. Go to original source... Go to PubMed...
    5. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265: 2037-2048. Go to original source... Go to PubMed...
    6. Rogus JJ, Warram JH, Krolewski AS. Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset. Diabetes 2002; 51: 1655-1662. Go to original source... Go to PubMed...
    7. Strauch K, Fimmers R, Baur MP et al. How to model a complex trait. 1. General considerations and suggestions. Hum Hered 2003; 55: 202-210. Go to original source... Go to PubMed...
    8. Glazier AM, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. Science 2002; 298: 2345-2349. Go to original source... Go to PubMed...
    9. Ruiz J. Diabetes mellitus and the late complications: influence of the genetic factors. Diabetes Metab 1997; 23(Suppl 2): 57-63.
    10. Seaquist ER, Goetz FC, Rich S et al. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-1165. Go to original source... Go to PubMed...
    11. Borch-Johnsen K, Norgaard K, Hommel E et al. Is diabetic nephropathy an inherited complication? Kidney Int 1992; 41: 719-722. Go to original source... Go to PubMed...
    12. Quinn M, Angelico MC, Warram JH et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996; 39: 940-945. Go to original source... Go to PubMed...
    13. Faronato PP, Maioli M, Tonolo G et al. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Diabetologia 1997; 40: 816-823. Go to original source... Go to PubMed...
    14. Pettitt DJ, Saad MF, Bennett PH et al. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 438-443. Go to original source... Go to PubMed...
    15. Canani LH, Gerchman F, Gross JL. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes 1999; 48: 909-913. Go to original source... Go to PubMed...
    16. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995; 25: 710-713. Go to original source... Go to PubMed...
    17. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997; 46: 1829-1839.
    18. Krolewski AS, Warram JH, Christlieb AR et al. The changing natural history of nephropathy in type I diabetes. Am J Med 1985; 78: 785-794. Go to original source... Go to PubMed...
    19. Imperatore G, Knowler WC, Pettitt DJ et al. Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes 2000; 49: 1049-1056. Go to original source... Go to PubMed...
    20. Fogarty DG, Hanna LS, Wantman M et al. Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes 2000; 49: 1057-1063. Go to original source... Go to PubMed...
    21. Imperatore G, Knowler WC, Nelson RG et al. Genetics of diabetic nephropathy in the Pima Indians. Curr Diab Rep 2001; 1: 275-281. Go to original source... Go to PubMed...
    22. Vardarli I, Baier LJ, Hanson RL et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 2002; 62: 2176-2183. Go to original source... Go to PubMed...
    23. Imperatore G, Hanson RL, Pettitt DJ et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998; 47: 821-830. Go to original source... Go to PubMed...
    24. Moczulski DK, Rogus JJ, Antonellis A et al. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 1998; 47: 1164-1169. Go to original source... Go to PubMed...
    25. Yu H, Bowden DW, Spray BJ et al. Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. J Am Soc Nephrol 1996; 7: 2559-2564. Go to original source... Go to PubMed...
    26. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247. Go to original source... Go to PubMed...
    27. Fogarty DG, Rich SS, Hanna L et al. Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. Kidney Int 2000; 57: 250-257. Go to original source... Go to PubMed...
    28. Freedman BI, Beck SR, Rich SS et al. A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension 2003; 42: 291-296. Go to original source... Go to PubMed...
    29. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh J (ed). Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press 1990: 81-100.
    30. DeWan AT, Arnett DK, Atwood LD et al. A genome scan for renal function among hypertensives: the HyperGEN study. Am J Hum Genet 2001; 68: 136-144. Go to original source... Go to PubMed...
    31. Warram JH, Scott LJ, Hanna LS et al. Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia. Diabetes 2000; 49: 94-100. Go to original source... Go to PubMed...
    32. Freedman BI, Bowden DW, Rich SS et al. Genetic initiation of hypertensive and diabetic nephropathy. Am J Hypertens 1998; 11: 251-257. Go to original source... Go to PubMed...
    33. Brown DM, Provoost AP, Daly MJ et al. Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat Genet 1996; 12: 44-51. Go to original source... Go to PubMed...
    34. Freedman BI, Rich SS, Yu H et al. Linkage heterogeneity of end-stage renal disease on human chromosome 10. Kidney Int 2002; 62: 770-774. Go to original source... Go to PubMed...
    35. Hunt SC, Hasstedt SJ, Coon H et al. Linkage of creatinine clearance to chromosome 10 in Utah pedigrees replicates a locus for end-stage renal disease in humans and renal failure in the fawn-hooded rat. Kidney Int 2002; 62: 1143-1148. Go to original source... Go to PubMed...
    36. Iyengar SK, Fox KA, Schachere M et al. Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy. J Am Soc Nephrol 2003; 14: S195-S201. Go to original source... Go to PubMed...
    37. Staessen JA, Wang JG, Ginocchio G et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15: 1579-1592. Go to original source... Go to PubMed...
    38. Fujisawa T, Ikegami H, Kawaguchi Y et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 1998; 41: 47-53. Go to original source... Go to PubMed...
    39. Kunz R, Bork JP, Fritsche L et al. Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. J Am Soc Nephrol 1998; 9: 1653-1663. Go to original source... Go to PubMed...
    40. Hadjadj S, Fanelli A, Torremocha F et al. Prospective follow-up study of renal function in type 2 diabetes. Arch Mal Coeur Vaiss 2001; 94: 928-932. Go to PubMed...
    41. Jacobsen P, Tarnow L, Carstensen B et al. Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 2003; 14: 2843-2850. Go to original source... Go to PubMed...
    42. Krolewski AS, Warram JH, Valsania P et al. Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med 1991; 90: 56S-61S. Go to original source... Go to PubMed...
    43. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
    44. Lee KE, Klein BE, Klein R. Familial aggregation of components of the multiple metabolic syndrome in the Framingham Heart and Offspring Cohorts: Genetic Analysis Workshop Problem 1. BMC Genet 2003; 4(Suppl 1): S94. Go to original source... Go to PubMed...
    45. Narayan KM, Pettitt DJ, Hanson RL et al. Familial aggregation of medial arterial calcification in Pima Indians with and without diabetes. Diabetes Care 1996; 19: 968-971. Go to original source... Go to PubMed...
    46. Wagenknecht LE, Bowden DW, Carr JJ et al. Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes 2001; 50: 861-866. Go to original source... Go to PubMed...
    47. Lange LA, Bowden DW, Langefeld CD et al. Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke 2002; 33: 1876-1881. Go to original source... Go to PubMed...
    48. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644. Go to original source... Go to PubMed...
    49. Samani NJ, Thompson JR, O'Toole L et al. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-712. Go to original source... Go to PubMed...
    50. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 2000; 20: 484-492. Go to original source... Go to PubMed...
    51. Keavney B, McKenzie C, Parish S et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5 000 cases and 6 000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000; 355: 434-442. Go to original source... Go to PubMed...
    52. Škrha J. Diabetes mellitus - a risk factor for cardiovascular diseases. Vnitř Lék 2001; 47(5): 281-284.
    53. Krušová D. Antihypertensives and their importance in the initial stages of diabetic nephropathy. Vnitř Lék 1999; 45(11): 664-669. Go to PubMed...
    54. Krahulec B, Vozar J. Incidence of risk factors and vascular complications in patients with newly diagnosed type 2 diabetes mellitus. Vnitř Lék 2002; 48(11): 1031-1038. Go to PubMed...
    55. Morgan CL, Currie CJ, Stott NC et al. The prevalence of multiple diabetes-related complications. Diabet Med 2000; 17: 146-151. Go to original source... Go to PubMed...
    56. Rychlík I, Sulková S. Diabetes mellitus and chronic renal insufficiency. Vnitř Lék 2003; 49(5): 395-402. Go to PubMed...
    57. Monhart V. Hypertension and chronic renal insufficiency-chronic kidney failure. Vnitř Lék 2003; 49(5): 388-394. Go to PubMed...
    58. Lindner TH, Monks D, Wanner C et al. Genetic aspects of diabetic nephropathy. Kidney Int 2003; Suppl. S186-S191. Go to original source... Go to PubMed...
    59. Krolewski AS, Ng DP, Canani LH et al. Genetics of diabetic nephropathy: how far are we from finding susceptibility genes? Adv Nephrol Necker Hosp 2001; 31: 295-315. Go to PubMed...
    60. Bowden DW. Genetics of diabetes complications. Curr Diab Rep 2002; 2: 191-200. Go to original source... Go to PubMed...
    61. Genetic determinants of diabetic nephropathy: The family investigation of nephropathy and diabetes (FIND). J Am Soc Nephrol 2003; 14: S202-S204. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.